| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |